Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis) - PubMed (original) (raw)

Observational Study

Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis)

Adriana J van Ballegooijen et al. J Am Coll Cardiol. 2014.

Abstract

Objectives: This study investigated whether lower 25-hydroxyvitamin D and higher parathyroid hormone concentrations are associated with incident hypertension.

Background: Disturbances in vitamin D metabolism are plausibly related to hypertension.

Methods: MESA (Multi-Ethnic Study of Atherosclerosis) is a community-based, prospective cohort with baseline measurements obtained between 2000 and 2002. We studied 3,002 men and women free of prevalent cardiovascular disease and hypertension, age 45 to 84 years at baseline. Serum 25-hydroxyvitamin D and intact parathyroid hormone were measured from previously frozen baseline samples using liquid chromatography-mass spectroscopy and a 2-site immunoassay, respectively. We used a complementary log-log model with interval censoring to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for 25-hydroxyvitamin D and parathyroid hormone concentrations with incident hypertension through 2010.

Results: During a median follow-up of 9.0 years, 41% of the cohort (n = 1,229) developed hypertension. Mean serum 25-hydroxyvitamin D was 26.3 ± 11.2 ng/ml and mean parathyroid hormone was 41.2 ± 17.3 pg/ml. Compared with 25-hydroxyvitamin D ≥30 ng/ml, 25-hydroxyvitamin D <20 ng/ml was associated with a greater hypertension risk (HR: 1.28 [95% CI: 1.09 to 1.50]), although the association was attenuated and not statistically significant after adjusting for potential confounders (HR: 1.13 [95% CI: 0.96 to 1.33]). Compared with parathyroid hormone <33 pg/ml, parathyroid hormone ≥65 pg/ml was associated with a significantly greater risk of hypertension (HR: 1.27 [95% CI: 1.01 to 1.59]) after adjusting for potential confounders.

Conclusions: Lower 25-hydroxyvitamin D concentrations were not associated with a greater risk of incident hypertension. Higher serum parathyroid hormone concentrations showed a significant, but statistically marginal, relationship to the development of hypertension. These findings will require further confirmation. (Multi-Ethnic Study of Atherosclerosis; NCT00005487).

Keywords: incident hypertension; parathyroid hormone; prospective study; vitamin D.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1

Flow diagram of incident hypertension ascertainment for each MESA examination

Figure 2. Continuous Associations of 25(OH)D (A) and PTH (B) Concentrations with Incident Hypertension

Adjusted dose-response relations of serum 25-hydroxyvitamin D (A) and parathyroid hormone (B) concentrations with incident hypertension.

Figure 2. Continuous Associations of 25(OH)D (A) and PTH (B) Concentrations with Incident Hypertension

Adjusted dose-response relations of serum 25-hydroxyvitamin D (A) and parathyroid hormone (B) concentrations with incident hypertension.

Figure 3. Associations of 25(OH)D (A) and PTH (B) with Incident Hypertension by BMI-categories

Associations between categories of 25-hydroxyvitamin D (A) and parathyroid hormone (B) with incident hypertension within three different BMI categories.

Figure 3. Associations of 25(OH)D (A) and PTH (B) with Incident Hypertension by BMI-categories

Associations between categories of 25-hydroxyvitamin D (A) and parathyroid hormone (B) with incident hypertension within three different BMI categories.

Cited by

Association of parathyroid hormone with risk of hypertension and type 2 diabetes: a dose-response meta-analysis.
Feng M, Xu M, Wang Q, Xia S, Yu C, Li M, Liu Y. Feng M, et al. BMC Cardiovasc Disord. 2024 Jan 3;24(1):13. doi: 10.1186/s12872-023-03682-1. BMC Cardiovasc Disord. 2024. PMID: 38172768 Free PMC article.
Review Article on Molecular Mechanism of Regulation of Hypertension by Macro-elements (Na, K, Ca and Mg), Micro-elements/Trace Metals (Zn and Cu) and Toxic Elements (Pb and As).
Joshi A, Kaur S, Taneja SK, Mandal R. Joshi A, et al. Biol Trace Elem Res. 2024 Apr;202(4):1477-1502. doi: 10.1007/s12011-023-03784-z. Epub 2023 Jul 31. Biol Trace Elem Res. 2024. PMID: 37523058 Review.
Development and Validation of Vitamin D- Food Frequency Questionnaire for Moroccan Women of Reproductive Age: Use of the Sun Exposure Score and the Method of Triad's Model.
Zouine N, Lhilali I, Menouni A, Godderis L, El Midaoui A, El Jaafari S, Zegzouti Filali Y. Zouine N, et al. Nutrients. 2023 Feb 4;15(4):796. doi: 10.3390/nu15040796. Nutrients. 2023. PMID: 36839154 Free PMC article.
Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress.
Renke G, Starling-Soares B, Baesso T, Petronio R, Aguiar D, Paes R. Renke G, et al. Nutrients. 2023 Feb 2;15(3):769. doi: 10.3390/nu15030769. Nutrients. 2023. PMID: 36771474 Free PMC article. Review.
Vitamin D Deficiency Association with Comorbid Diseases in Palestine: "A Cross-Sectional Observation Study".
Abukhalil AD, Falana H, Hamayel R, Yasser F, Nasser A, Naseef H, Al-Shami N, Rabba A. Abukhalil AD, et al. Int J Gen Med. 2022 Nov 2;15:8033-8042. doi: 10.2147/IJGM.S389190. eCollection 2022. Int J Gen Med. 2022. PMID: 36348976 Free PMC article.

References

1. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8. - PubMed
1. Jorde R, Svartberg J, Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. J Hypertens. 2005;23:1639–44. - PubMed
1. Taylor EN, Curhan GC, Forman JP. Parathyroid hormone and the risk of incident hypertension. J Hypertens. 2008;26:1390–4. - PubMed
1. Anderson JL, Vanwoerkom RC, Horne BD, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors? Am Heart J. 2011;162:331–9. - PubMed
1. Tomaschitz A, Ritz E, Pieske B, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res. 2012;94:10–9. - PubMed

Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis) - PubMed (original) (raw)